ROS1 gene mutation; ROS1 gene fusion; ROS1 gene rearrangement

From Aaushi
Jump to navigation Jump to search

Indications

Clinical significance

More general terms

Additional terms

References

  1. 1.0 1.1 1.2 Pal S. Crizotinib Tx Stakes Claim in ROS1-Positive NSCLC. The TKI boosts outcomes in those with a rare disease -- enough to convince FDA to approve the agent fast and early. MedPage Today. ASCO Reading Room. Feb 9, 2018 https://www.medpagetoday.com/reading-room/asco/lung-cancer/71049
    Gainor JF, Tseng D, Yoda S et al Patterns of metastatic spread and mechanisms of resistance to crizotinib in ROS1-positive non-small cell lung cancer. JCO Precision Oncology. Epub 2017 Aug 16. PMID: https://www.ncbi.nlm.nih.gov/pubmed/29333528 Free PMC Article
  2. 2.0 2.1 ARUP Consult: Lung cancer deprecated reference